Colorectal cancer resource library

    Showing 1–20 of 39 results

    Filtered By:
    Susan Burke: Up and running after minimally invasive surgeries
    Blog

    Susan Burke: Up and running after minimally invasive surgeries

    Susan Burke’s journey with colorectal cancer started with an appendectomy. At 47 years old, a pain in her right, lower abdomen for more than a year led doctors to find an appendix that was swollen to three times its normal size.

    Before your surgery
    Blog

    Before your surgery

    It is important to discuss your surgical options with your surgeon and medical team, along with details about surgery preparation and recovery.

    Techniques used for colorectal cancer surgery
    Blog

    Types of colorectal cancer surgery

    Surgery is considered the most common treatment for early stage or resectable (removable) colorectal cancers. Doctors will evaluate which type of surgery is best for a patient, depending on the extent of the tumor, where it is located. The three main types of surgery for colorectal cancer are open, laparoscopic, and robotic.

    Could minimally invasive surgery be right for me?
    Blog

    Could minimally invasive surgery be right for me?

    Minimally invasive surgery (MIS) has gained popularity since its introduction. MIS can be performed in patients with colorectal cancer to achieve a variety of outcomes, including the removal of a portion of the colon, removal of the entire colon, creating an ostomy, or reconnecting and reconstructing the colon.

    Is minimally invasive surgery a good choice for you?
    Blog

    Is minimally invasive surgery a good choice for you?

    The use of minimally invasive surgery (MIS) in colorectal surgery has been increasing in recent years. Multiple studies have shown that when appropriate, MIS procedures are as safe as open surgeries.

    What is minimally invasive surgery?
    Blog

    What is minimally invasive surgery?

    Colorectal cancer is the one of the most common malignancies affecting both men and women. Surgery is the main treatment for resectable colorectal cancer and especially for patients diagnosed in early stages. During surgery, the section of the colon that harbors the tumor alongside the surrounding healthy tissue and nearby lymph nodes are removed.

    Blog

    Keytruda approved for MSI-H colorectal cancer patients

    Merck's Keytruda has been approved by the FDA for patients with a microsatellite instability-high (also known as MSI-H) or a mismatch repair deficient (dMMR) biomarker following progression on a fluoropyrimidine, oxaliplatin, and irinotecan.

    What is Immunoscore?
    Blog

    What is Immunoscore?

    This new technology could refine the prognosis of stage II and some low-risk stage III colon cancer patients and provide doctors with additional information when making decisions about chemotherapy treatment.

    Perspectives on Robotic Surgery for Colorectal Procedures
    Blog

    Perspectives on robotic surgery for colorectal procedures

    Open surgery is the most common type of surgery in the United States. But given advancements in surgical technology, it may not be the best thing for all patients. The good news is colorectal patients may have other minimally invasive surgical options.

    Blog

    FDA approves new treatment for metastatic CRC with BRAF mutation

    The U.S. Food and Drug Administration has approved encorafenib (marketed as BRAFTOVI) in combination with cetuximab (marketed as ERBITUX) as a second-line therapy for the treatment of adult patients with metastatic colorectal cancer with a BRAFV600E mutation.

    Blog

    Why the doctors chose robotic-assisted surgery

    In the case of Dr. Paul O'Rourke – a 39-year-old, stage I rectal cancer survivor, and physician at Johns Hopkins – robotic-assisted surgery (RAS) was the surgical option he was fortunate he had.

    Clinical Trial To Evaluate Onvansertib as First-Line mCRC Treatment
    Blog

    Clinical trial to evaluate onvansertib as first-line mCRC treatment

    People with RAS-mutated metastatic colorectal cancer (mCRC) have seen little progress in first-line treatment options over the past two decades, but that could soon change for thousands of new patients, according to a press release from Cardiff Oncology.

    support group three people

    Get connected with your allies

    There are many ways to find your community through the Alliance. Try one of our online communities.

    Learn More